ORCHIDCHEM 
Orchid Chemicals & Pharmaceuticals Ltd
How do you think orchidchem will perform against the NIFTY? Pick this stock
CAPITAL4 COMMUNITY
All: Members who that have picked this stock: 60
58 outperforms
2 underperforms
Stars: Top Investors who have picked this stock: 9
9 outperforms
0 underperforms
CLASSIFICATION | SECTOR | INDUSTRY |
|---|---|---|
| Primary | Pharma & Healthcare | Pharmaceuticals |
SNAPSHOT
- BSE Code / NSE Ticker
- 524372 / ORCHIDCHEM
- Last traded time
- 2012-05-23 15:59:09
- Last traded on
- BSE
- Intra-day Low / High
- 117.4 / 124.1
- 52w closing Low / High
- 119.3 / 292.0
- Today Volume
- 2,898,530
- 30d avg Daily Volume
- 2,391,259
- Market Cap
- INR 840.5 cr
- P/E Ratio TTM
- 7.85
- Historical Performance
- Today
- Weekly
- Monthly
- 3 Months
- 1 Year
- -3.6%
- -6.2%
- -33.8%
- -33.6%
- -54.4%
valuation snapshotpeer comparisonfinancialsshare holdingmf holdingcommunity picksbrokerage picks futures & options
Shareholding Mutual Fund Holding
Source: Capital Market
| No Of shares | % Share Holding | |
| Total Foreign | 13050979 | 18.53 |
| Total Institutions | 3296340 | 4.68 |
| Total Govt Holding | 0 | 0.00 |
| Total Non Promoter Corporate Holding | 13342559 | 18.94 |
| Total Promoters | 22840781 | 32.43 |
| Total Public & others | 17911417 | 25.43 |
| Total | 70442076 | 100 |
Source: Capital Market
CAPITAL4 COMMUNITY
STOCK SCREENERS
INDIA CAPITAL MARKETS
ORCHIDCHEM IN THE NEWS
- May-16 8:07 Orchid Chemicals & Pharmaceuticals net profit declines 66.47% in the March 2012 quarter
- May-08 12:39 Orchid Pharma receives USFDA approval for Naratriptan Tabs ANDA
- May-08 11:09 Orchid Chemicals & Pharmaceuticals to consider dividend
- Apr-05 9:25 Hon'ble High Court approves scheme of amalgamation of Orchid Chemicals & Pharmaceuticals
- Feb-08 15:00 Orchid Chemicals & Pharmaceuticals reports net loss of Rs 10.12 crore in the December 2011 quarter
- Feb-07 11:07 Orchid Chemicals & Pharmaceuticals receives USFDA approval
- Jan-11 9:56 Orchid Chemicals & Pharmaceuticals' board approves scheme of amalgamation
- Dec-30 16:28 Orchid Chemicals & Pharmaceuticals to hold board meeting
- Dec-23 11:28 Orchid's drug discovery research initiative with Merck advances anti-infective program meets preclinical milestone
TOP BLOGS
- Advice for – Tuesday, May 22, 2012
by ABHISHEK-PARAKH
(Recommendations: 6) - Money can be made in all market conditions
by ASHOKSHARMA
(Recommendations: 7) - The problem with historical returns
by ROHIT CHAUHAN
(Recommendations: 9) - Markets: What next?
by Nishit_Vadhavkar
(Recommendations: 8) - Nifty – RSI at sub 30. Highly Oversold – Bottoming out in next few sessions
by NOORESH MERANI
(Recommendations: 9) - Follow up: Gujarat reclaim & rubber products ltd
by ROHIT CHAUHAN
(Recommendations: 9) - Negative news drags the markets down
by Nishit_Vadhavkar
(Recommendations: 7) - Option strategy worked will in such unpredictable market
by ASHOKSHARMA
(Recommendations: 8) - Sensex- Technical Outlook and Trading Levels, 8 April 2012
by D_Sathiamoorthy
(Recommendations: 5) - Insourcing vs. outsourcing government functions: A setback for public sector production of elementary education
by AJAY SHAH
(Recommendations: 7) - Crucial Week Ahead
by Nishit_Vadhavkar
(Recommendations: 8) - A few contrarian thoughts
by ROHIT CHAUHAN
(Recommendations: 8)
Company and Mutual Fund Finder
| Company: | 3ABCDEFGHIJKLMNOPQRSTUVWXYZ |
| Indices: | NIFTY | SENSEX | BSE 100 | BSE 200 | BSE 500 | BSE MIDCAP | BSE SMALLCAP | BSE AUTO | BSE BANKEX | BSE CD | BSE CG | BSE FMCG | BSE HC | BSE IT | BSE METAL | BSE OIL | BSE POWER | BSE PSU | BSE REALTY | BSE TECK | BSE DOLLEX | DOLLEX 100 | DOLLEX 200 | NIFTY JUNIOR | CNX MIDCAP | NIFTY MID50 | BANK NIFTY | CNX IT | CNX100 | CNX 500 | CNX DEFTY |
| Mutual Funds: | AIG Global Investment | AXIS | Baroda Pioneer | Benchmark | Bharti AXA | Birla Sun Life | Canara Robeco | Deutsche | DSP BlackRock | Edelweiss | Escorts | Fidelity | Fortis | Franklin Templeton | HDFC | HSBC | ICICI Prudential | IDBI | IDFC | ING | JM Financial | JP Morgan | Kotak Mahindra | L&T | LIC | Mirae Asset | Morgan Stanley | Motilal Oswal | Peerless | Pramerica | PRINCIPAL | Quantum | Reliance | Religare | Sahara | SBI | Shinsei | Sundaram BNP Paribas | Tata | Taurus | UTI |